Influence of the treatment with recombinant human erythropoietin on plasma concentration of interleukin-1-alpha and tumour necrosis factor-alpha in hemodialyzed subjects

Nephron. 1993;64(2):333-4. doi: 10.1159/000187347.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia / blood
  • Anemia / drug therapy
  • Erythropoietin / pharmacology*
  • Female
  • Humans
  • Interleukin-1 / blood*
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Renal Dialysis*
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Erythropoietin